window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 19, 2026

  • News
  • About Us
Contact Us

Real world evidence

  • Biologics & Biosimilars,Chronic diseases,Clinical Development,Clinical Trials,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Regulatory Affairs

    Saphnelo self-administration Phase 3 trial meets primary endpoint in systemic lupus erythematosus

    AstraZeneca has reported positive interim results from the Phase 3 [...]

    September 22, 2025
  • Events and Conferences,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    September 22, 2025
  • Clinical Development,Clinical Trials,Data Management,Patient Centricity,Real world evidence,Research & Development

    TransCelerate and Tufts study finds nearly one-third of clinical trial data adds limited value

    A new collaborative study from TransCelerate BioPharma and the Tufts [...]

    September 22, 2025
  • Clinical Trials,Data Management,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence

    Almirall study shows psoriasis treatment improves skin and psychological well-being

    Almirall has presented new two-year results from its POSITIVE study [...]

    September 18, 2025
  • Artificial Intelligence,Oncology,Precision medicine,Real world evidence,Research & Development,Women in Pharma

    Imagene AI and Sheba Medical Center form alliance to expand precision oncology with real-world data

    Imagene AI has expanded its collaboration with Sheba Medical Center [...]

    September 17, 2025
  • Chronic diseases,Data Management,Drug Development,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    New Phesi data shows more than 100 diseases being studied with GLP-1 therapies

    Analysis highlights potential for benefits far beyond obesity, signalling a [...]

    September 12, 2025
  • Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Precision medicine,Real world evidence

    Cemiplimab plus chemotherapy shows five-year survival benefit in advanced NSCLC Empower-lung 3 trial

    Regeneron UK Limited has reported five-year follow-up results from the [...]

    September 10, 2025
  • Clinical Trials,Data Management,Real world evidence,Regulatory Affairs

    Clinical trials: TransCelerate and FDA explore pragmatic trial designs to broaden patient access

    TransCelerate BioPharma and the US Food and Drug Administration (FDA) [...]

    August 20, 2025
  • Digital Health,Drug Development,Global health,Market Access & Commercialization,Patient Centricity,Real world evidence,Women's Health

    Patient voices take centre stage as Currax leans into authenticity in obesity care

    As debate continues over the cost and sustainability of GLP-1 [...]

    August 5, 2025
  • Artificial Intelligence,Clinical Development,Global health,Patient Centricity,Real world evidence,Research & Development

    Briya launches clinical-grade AI assistant for accelerating medical and epidemiological research

    New AI platform designed to support faster discovery, better study [...]

    August 1, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth
    Categories: Biotech, Clinical Development, Clinical studies, Clinical Trials, Healthcare leadership, Movers & Shakers, Rare Diseases
  • Will Edwards appointed CEO as Astoriom expands international storage and biorepository operations
    Categories: Biomanufacturing, CDMOs & Manufacturing, Healthcare leadership, Movers & Shakers, Pharmaceuticals and therapeutics
  • CombinAbleAI to be acquired by insitro to expand AI drug discovery platform
    Categories: Artificial Intelligence, Biotech, Drug Development, Mergers & Acquisitions, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top